These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6157579)

  • 21. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
    Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
    Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pseudo-T cell defect in bullous pemphigoid].
    Schaller J; Haustein UF; Lohrisch I
    Dermatol Monatsschr; 1986; 172(6):318-24. PubMed ID: 3527800
    [No Abstract]   [Full Text] [Related]  

  • 23. [Plasma exchange therapy in pemphigus vulgaris and bullous pemphigoid--our clinical experiences and the role of bullous pemphigoid antibody in blister formation].
    Watanabe S
    Nihon Hifuka Gakkai Zasshi; 1983 Aug; 93(9):953-64. PubMed ID: 6363766
    [No Abstract]   [Full Text] [Related]  

  • 24. Conversion of pemphigoid gestationis to bullous pemphigoid--two refractory cases highlighting this association.
    Jenkins RE; Jones SA; Black MM
    Br J Dermatol; 1996 Oct; 135(4):595-8. PubMed ID: 8915153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bullous pemphigoid.
    Korman NJ
    Dermatol Clin; 1993 Jul; 11(3):483-98. PubMed ID: 8365034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of bullous pemphigoid: recommendations for immunomodulatory treatments.
    Kirtschig G; Khumalo NP
    Am J Clin Dermatol; 2004; 5(5):319-26. PubMed ID: 15554733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bullous pemphigoid.
    Bağcı IS; Horváth ON; Ruzicka T; Sárdy M
    Autoimmun Rev; 2017 May; 16(5):445-455. PubMed ID: 28286109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell mediated immunity in patients with Virchowian hanseniasis before and after treatment with transfer factor.
    Leser PG; Margarido L; Belda W; Sartori SG; Hares WA; Freire CA; Fleury R; Montenegro MR; Leser W; Naspitz CK
    Hansenol Int; 1980 Jun; 5(1):3-27. PubMed ID: 7042563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune bullous eruption localized to a breast reconstruction site: response to niacinamide.
    Honl BA; Elston DM
    Cutis; 1998 Aug; 62(2):85-6. PubMed ID: 9714904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eosinophils as putative therapeutic targets in bullous pemphigoid.
    Simon D; Borradori L; Simon HU
    Exp Dermatol; 2017 Dec; 26(12):1187-1192. PubMed ID: 28833620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bullous pemphigoid and prurigo nodularis.
    Roenigk RK; Dahl MV
    J Am Acad Dermatol; 1986 May; 14(5 Pt 2):944-7. PubMed ID: 3519701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
    van Beek N; Schulze FS; Zillikens D; Schmidt E
    Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid.
    Pickford WJ; Gudi V; Haggart AM; Lewis BJ; Herriot R; Barker RN; Ormerod AD
    Clin Exp Immunol; 2015 May; 180(2):189-200. PubMed ID: 25472480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical study of toll-like receptors 2, 4, and 9 expressions in pemphigus and bullous pemphigoid lesions.
    Sun XK; Chen JF; Shen H
    Arch Dermatol Res; 2016 Aug; 308(6):429-36. PubMed ID: 27221282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bullous pemphigoid.
    Korman N
    J Am Acad Dermatol; 1987 May; 16(5 Pt 1):907-24. PubMed ID: 3294944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose methylprednisolone in the treatment of bullous pemphigoid.
    Siegel J; Eaglstein WH
    Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prodrome of bullous pemphigoid.
    Amato DA; Silverstein J; Zitelli J
    Int J Dermatol; 1988 Oct; 27(8):560-3. PubMed ID: 3061948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of very low doses of intravenous immunoglobulins for the treatment of bullous pemphigoid].
    Adoue D; Vilain C; Fontan B; Le Tallec Y; Albarède JL; Oksman F
    Presse Med; 1987 Oct; 16(33):1625-7. PubMed ID: 2959923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation between immunologic reactivity and the clinical development in a case of bullous pemphigoid].
    Renoux M; Paulay AM; Carli-Basset C; Lorette G; Renoux G
    Ann Dermatol Venereol; 1980; 107(11):1095-6. PubMed ID: 7015971
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnosis and classification of pemphigus and bullous pemphigoid.
    Kershenovich R; Hodak E; Mimouni D
    Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.